A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck

Technology in Cancer Research and Treatment

Volumn 1, Issue 2, 2002, Pages 133-140

  Regine, William F ^a   Valentino, Joseph ^b   Arnold, Susanne M ^c   Sloan, David ^a   Kenady, Daniel ^a   Strottmann, James ^a   Mohiuddin, Mohammed ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Division of Otolaryngology   (United States)

^c Division of Gynecologic Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ANGIOGRAPHY; ANXIETY; ARTERY OCCLUSION; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CATHETER; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EXTERNAL CAROTID ARTERY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INFECTION; MUCOSA; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROLOGIC DISEASE; PHASE 2 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; SIDE EFFECT; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; TECHNOLOGY; TREATMENT OUTCOME; VOMITING;

EID: 0038330307     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100206     Document Type: Article

References (42)

1. Jacobs C. Adjuvant chemotherapy for head and neck cancer. J Clin Oncol. 7, 823-826 (1989).
2. Vokes EE. Head and Neck Cancer. in Chemotherapy Source Book. pp 918-931. Ed. MC Perry, Williams and Wilkins, Baltimore (1992).
3. Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., Ensley, J. F. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 16, 1310-1317 (1998).
4. Al-Sarraf, M., Pajak, T. F., Marcial, V. A., Mowry, P., Cooper, J. S., Stetz, J., Ensley, J. F., Velez-Garcia, E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer. 59, 259-265 (1987).
5. Douple E, Richmond RC, Logan ME. Therapeutic potentiation in a mouse mammary tumor and an intracerebral rat brain tumor by combined cisdicholorodiamine-platinum (II) and radiation. J Clin Hematol Oncol. 7, 585-603 (1977).
6. Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., Prosnitz, L. R. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [see comments]. N Engl J Med. 338, 1798-1804 (1998).
7. Jeremic, B., Shibamoto, Y., Milicic, B., Nikolic, N., Dagovic, A., Aleksandrovic, J., Vaskovic, Z., Tadic, L. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 18, 1458-1464 (2000).
8. Koch, W. M., Lee, D. J., Eisele, D. W., Miller, D., Poole, M., Cummings, C. W., Forastiere, A. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 121, 974-980 (1995).
9. Pfister, D. G., Strong, E., Harrison, L., Haines, I. E., Pfister, D. A., Sessions, R., Spiro, R., Shah, J., Gerold, F., McLure, T. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol. 9, 850-859 (1991).
10. Colevas, A. D., Busse, P. M., Norris, C. M., Fried, M., Tishler, R. B., Poulin, M., Fabian, R. L., Fitzgerald, T. J., Dreyfuss, A., Peters, E. S., Adak, S., Costello, R., Barton, J. J., Posner, M. R. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial. J Clin Oncol 16, 1331-1339 (1998).
11. Shin, D. M., Glisson, B. S., Khuri, F. R., Ginsberg, L., Papadimitrakopoulou, V., Lee, J. J., Lawhorn, K., Gillenwater, A. M., Ang, K. K., Clayman, G. L., Callender, D. L., Hong, W. K., Lippman, S. M. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol. 16, 1325-1330 (1998).
12. Siu LL, Czaykowski PM, Tannock IF. Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx. J Clin Oncol. 16, 2514-2521 (1998).
13. Vokes, E. E., Kies, M., Haraf, D. J., Mick, R., Moran, W, J., Kozloff, M., Mittal, B., Pelzer, H., Wenig, B., Panje, W. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol. 13, 876-883 (1995).
14. Seong, J., Keum, K. C., Han, K. H., Lee, D. Y., Lee, J. T., Chon, C. Y., Moon, Y. M., Suh, C. O., Kim, G. E. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 43, 393-397 (1999)
15. Chaney, A. W., Eifel, P. J., Logsdon, M. D., Morris, M., Wharton, J. T. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 45, 113-118 (1999).
16. Madajewicz, S., Chowhan, N., Tfayli, A., Roque, C., Meek, A., Davis, R., Wolf, W., Cabahug, C., Roche, P., Manzione, J., Iliya, A., Shady, M., Hentschel, P., Atkins, H., Braun, A. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 88, 2350-2356 (2000).
17. Fuwa, N., Ito, Y., Matsumoto, A., Kamata, M., Kodaira, T., Furutani, K., Sasaoka, M., Kimura, Y., Morita, K. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma - A phase I study Cancer 89, 2099-2105 (2000).
18. Damascelli, B., Cantu, G., Mattavelli, E, Tamplenizza, P., Bidoli, P., Leo, E., Dosio, F., Cerrotta, A. M., Di Tolla, G., Frigerio, L. F., Garbagnati, F., Lanocita, R., Marchiano, A., Patelli, G., Spreafico, C., Ticha, V., Vespro, V., Zunino, F. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007) - Phase I study of patients with squamous cell carcinoma of the head and neck and anal canal: Preliminary evidence of clinical activity. Cancer 92, 2592-2602 (2001).
19. Regine, W.F., Valentino, J., Arnold, S.M., Haydon, R.C., Sloan, D.A., Kenady, D.E., Strottmann, J.M., Pulmano, C., Mohiuddin, M. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 19, 3333-3339 (2001).
20. Regine, W. F., Valentino, J., John, W. J., Storey, G., Sloan, D. A., Kenady, D. E., Patel, P., Pulmano, C., Arnold, S., Mohiuddin, M. High-Dose Intra-Arterial Cisplatin and Concurrent Hyper-fractionated Radiation Therapy in Patients with Locally Advanced Primary Squamous Cell Carcinoma of the Head and Neck: Report of a Phase II Study. Head Neck 22, 543-549 (2000).
21. Robbins, K. T., Kumar, P., Regine, W. F., Wong, F. S. H., Weir, A. B., III, Flick, P., Kun, L. E., Palmer, R., Murray, T., Fontanesi, J., Ferguson, R., Thomas, R., Hartsell, W., Paig, C. U., Salazar, G., Norfleet, L., Hanchett, C. B., Harrington, V., Niell, B. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 38, 263-271 (1997).
22. Robbins, K. T., Storniolo, A. M., Kerber, C., Vicario, D., Seagren, S., Shea, M., Hanchett, C., Los, G., Howell, S. B. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J. Clin. Oncol. 12, 2113-2120 (1994).
23. Robbins, K. T., Vicario, D., Seagren, S., Weisman, R., Pellitteri, P., Kerber, C., Orloff, L., Los, G., Howell, S. B. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am. J. Surg. 168, 419-422 (1994).
24. Fu, K. K., Pajak, T. F., Trotti, A., Jones, C. U., Spencer, S. A., Phillips, T. L., Garden, A. S., Ridge, J. A., Cooper, J. S., Ang, K. K. A Radiation Therapy Oncology Group (RTOG) Phase III Randomized Study to Compare Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinomas: First Report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48, 7-16 (2000).
25. th ed. J.B. Lippincott Co., Philadelphia, PA (1993).
26. th ed, Lippincott-Raven, Philadelphia, PA (1998).
27. Kaplan E. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 475-481 (1953).
28. Horiot, J. C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardani, G., Van Den Bogaert, W., Danczak, S., Bolla, M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25, 231-241 (1992).
29. Parsons, J. T., Mendenhall, W. M., Stringer, S. P., Cassisi, N. J., Million, R. R. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck 15, 87-96 (1993).
30. Peters LJ, Ang KK, Thames HD, Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta. Oncol. 27, 185-194 (1998).
31. Thames, H. D., Jr., Peters, L. J., Withers, H. R., Fletcher, G. H. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int. J. Radiat. Oncol. Biol. Phys. 9, 127-138 (1983).
32. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta. Oncol. 27, 131-146 (1988).
33. Cox, J. D., Pajak, T. F., Marcial, V. A., Hanks, G. E., Mohiuddin, M., Fu, K. K., Byhardt, R. W., Rubin, P. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13. Int. J. Radiat. Oncol. Biol. Phys. 18, 515-521 (1990).
34. Fu, K. K., Pajak, T. F., Marcial, V. A., Ortiz, H. G., Rotman, M., Asbell, S. O., Coia, L. R., Vora, N. L., Byhardt, R., Rubin, P. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int. J. Radiat. Oncol. Biol. Phys. 32, 577-588 (1995).
35. Howell SB. Pharmacokinetic principles of regional chemotherapy. Contr. Oncol. 29, 1-8 (1988).
36. Howell SB, Tastle R. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat. Rep. 64, 611-616 (1980).
37. Johnson, C. R., Khandelwal, S. R., Schmidt-Ullrich, R. K., Ravalese III, J., Wazer, D. E. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32, 635-651 (1995).
38. Mancuso, A. A., Mukherji, S. K., Schmalfuss, I., Mendenhall, W., Parsons, J., Pameijer, F., Hermans, R., Kubilis, P. Preradiotherapy Computed Tomography as a Predictor of Local Control in Supraglottic Carcinoma. J Clin Oncol 17, 631-637 (1999).
39. Mukherji, S. K., O'Brien, S. M., Gerstle, R. J., Weissler, M., Shockley, W., Stone, J. A., Castillo, M. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. Head Neck, 22, 282-287 (2000).
40. Kumar, P., Robbins, K. T., Harris, J., McCulloch, T., Cmelak, A., Sofferman, R., Levin, P. Intra-Arterial (IA) cisplatin (P) and radiation therapy (RT) is feasible in a multi-insitutional setting for the treatment of stage IV-T4 head/neck (H/N) squamous cell carcinoma (SCCa): Initial results of radiation therapy Oncology Group (RTOG) trial 9615, Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #918, 230a, (2001).
41. Garden, A. A., Glisson, B. S., Ang, K. K., Morrison, W. H., Lippman, S., M., Byers, R. M., Geara, F., Clayman, G. L., Shin, D. M., Callender, D. L., Khuri, F. R., Goepfert, H., Hong, W. K., Peters, L. J. Phase I/II trail of radiation with chemotherapy boost for advanced squamous cell carcinomas of the head and neck: Toxicities and responses. J Clin Oncol. 17. 2390-2395 (1999).
42. Suntharalingam, M., Haas, M. L., Conley, B. A., Egorin, M. J., Levy, S., Sivasailam, S., Herman, J. M., Jacobs, M. C., Gray, W. C., Ord, R. A., Aisner, J. A., Van Echo, D. A. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 47, 49-56 (2000).